How ecstasy and psilocybin are shaking up psychiatry
Nature January 27, 2021 Paul Tullis 59 citations
Psilocybin, a natural hallucinogen, shows promise in treating depression and anxiety, with 71% of participants reporting significant symptom reduction after just two sessions. In a sample of 30 individuals, 60% experienced lasting improvements for over six months, comparable to effects seen with ecstasy in psychotherapy. This aligns with findings in psychoanalysis and psychology that highlight the potential of psychedelics to enhance emotional well-being. As psychiatry evolves, integrating such substances could reshape therapeutic approaches and broaden treatment options for mental health disorders.